PLXDC1 and neoplasm: PLXDC1 silencing in the HUVEC cells resulted in significant inhibition of cell migration, invasion, and tube formation compared with the results obtained using the control siRNA (Figure 3(C)), suggesting that PLXDC1 could be an important target for anti-angiogenesis tumor therapy.